AlgaeHealth Announces Successful NDI Petition with US FDA for AstaZine® Natural Astaxanthin

April 6th, 2016

 AlgaeHealth Announces Successful NDI Petition with US FDA for AstaZine® Natural Astaxanthin

Irvine California, April 6, 2016 – Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today that it has successfully petitioned the US FDA with a New Dietary Ingredients notification (NDI) for its flagship product AstaZine® Natural Astaxanthin.

 “We are happy to have received a letter of acknowledgement without objection from FDA for our flagship product, AstaZine® Natural Astaxanthin, which is derived from microalgae that we carefully cultivate in fully closed glass tube photobioreactors (PBRs) free from contamination,” said Joe Huff, CEO of AlgaeHealth’s US-based operation.  “Although we are not the first company to receive an NDI notification for Natural Astaxanthin, this NDI reinforces our commitment to provide the supplement industry with high quality ingredients that you can trust.”

AlgaeHealth produces AstaZine® in a variety of forms including Organic Certified 5% powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets.

*** ***

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeLife’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in late 2017.  The company has facilities in USA, Switzerland, Japan and China.

Further information on AlgaeHealth:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

 About BGG Group:

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae, natural vitamins, natural sweeteners and flavor enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400, has 5 production sites, international branches in USA, Switzerland, Japan and China and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified.

Further Information on BGG: www.bggworld.com

 Press Contact:

AlgaeHealth
Bob Capelli
Executive Vice President Global Marketing
bob@algaehealthsciences.com

808.345.7711 (USA)

BGG

BGG is a global leader in the manufacture and sourcing of clinically-supported ingredients for the dietary supplement, cosmetics, and food and beverage industries.

© 2017 Beijing Ginko Group